‘The clinical trials market will exceed $30BN by 2015’ says visiongain report.

Aug. 4, 2011 - PRLog -- Leading pharmaceutical manufacturers are increasingly seeking to outsource all stages of the drug development process. The main drivers for CRO revenue growth are the cost advantages of outsourcing and the regional and therapeutic expertise of research service providers. Off-shoring clinical trials to emerging markets, particularly India and China, will create revenue growth for global CROs. Indian and Chinese markets will grow with CAGRs over 20%, visiongain’s market analysis shows.

Richard Lang, pharmaceutical industry analyst, said: “Strong therapeutic experience and significant cost savings are driving Big Pharma to outsource drug development to CROs. Full service CROs will further benefit from multi-billion dollar strategic alliances during this decade. Niche market players will benefit from the increased demand for specialised clinical trial services, particularly in cancer and CNS disorders.”

Demand for late-stage development services has outgrown that for early-stage services in recent years. Pharma and biotech companies are increasingly focusing on near-registration projects to combat the impending patent cliff. Continued late-stage service demand will drive market growth from 2011 to 2015. Strategic alliances across full development programmes will secure long-term revenues for CROs.


Visiongain forecasts that the overall pharma clinical trial services market will grow rapidly to 2021. The future of the pharma clinical trial services market appears strong through increasing demand from many therapeutic areas, the report concludes. This new study complements visiongain’s wide range of analytical reports in healthcare and other industry areas.  


For further information about this report and an exec summary please click on:

http://www.visiongain.com/Report/641/Pharma-Clinical-Tria...

Please contact Sara Peerun
Email: sara.peerun@visiongainglobal.com
Tel +44 0 20 7336 6100
Web: www.visiongain.com

Table of Contents
1.   Executive Summary

2. Clinical Trials and Clinical Trial Services: An Introduction

3. The Pharmaceutical Clinical Trial Services Market 2011-2021

4. Key Therapeutic Areas in the Clinical Trial Services Market 2011-2021

5. Market-Leading CROs 2011-2021

6. Pharmaceutical Clinical Trial Services Market: Trends 2011-2021

7. Pharmaceutical Clinical Trial Services: Leading National Markets 2011-2021

8. Opinions from Our Research Interviews

9. Conclusions

ENDS

Notes for Editors

If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-2-business conferences, newsletters, management reports and e-zines focusing on the Pharmaceutical, Telecoms, Energy, Defence and Materials sectors.

Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port-of-call for the business professional, who needs independent, high quality, original material to rely and depend on.

# # #

Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-2-business conferences, newsletters, management reports and e-zines focusing on the Pharmaceutical, Telecoms, Energy, Defence and Materials sectors.

Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port-of-call for the business professional, who needs independent, high quality, original material to rely and depend on.